Been brewing since FDA approval of Voclosporin. Lots of reasons to speculate a buyout or possible merger with recent voluntary delisting from the TSX and remaining on NYSE. Excellent setup to be a cash cow. Target Price of $35 be EOY playing Oct Calls. and MRNA are LOADED with cash and you know they're sniffing out opportunities and would love to hear your thoughts and positions on this!